A sequence definition of the BALB/cJ IGHV3-6 region was performed. Ear samples from adult mice were digested in lysis buffer (100 mM Tris pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl) added 5 µl proteinase K (10 mg/ml, P6556, Sigma-Aldrich) at 55 C over night. Thereafter, the supernatants were treated with RNase A (VWR, A3832) at 100 µg/ml for 30 minutes at room temperature, which after the DNA was precipitated with pure isopropanol, washed in 70% ethanol and finally re-suspended in Tris-EDTA buffer. PCR was run using primers flanking the V H regions using forward primer 5'-gatgtacagcttcaggagtcaggacct-3' and a reverse primer 5'-tctcttgcacagtaatatgta-3'. The PCR products were TOPO-cloned using Zero blunt TOPO PCR cloning kit (Thermo Fisher Scientific). Colonies containing inserts were picked on Kanamycin LB plates. DNA was prepared from overnight cultures of single colonies using SV Miniprep kit (Promega). Small-scale DNA preps were sent for sequencing and analyzed. 
Materials and Methods

Generation of targeted VDJ H 315 knock-in mice
Mice that express the V-region of the M315 myeloma protein heavy chain, produced by the MOPC315 cell line (6) were generated by inserting the rearranged VDJ H 315 sequence into the D-J1-J4 region of the IgH locus through homologous recombination (see Fig. S2A above). First, the VDJ H 315 sequence was inserted next to the B1-8 promoter (derived from the pB1-8-LE vector, kindly supplied by Prof. K. Rajewsky) and fused to a Neo r -encoding selection cassette, flanked by FRT sites for removal. Homology arms for positioning were the same as for the VDJ H aId mouse (7) . Genomic targeting of BALB/c BL1 ES cells was performed at Ozgene Ltd. (Perth, Australia) as previously described (7) . Offspring were obtained by standard procedures and germline transmission was confirmed by Southern blot analysis (see Fig. S2B above) . VDJ H 315 mice were bred and maintained homozygous. Transgene expression was verified by PCR with primers annealing to the 5' Cre and the B1-8 promoter regions. Wild-type loci were detected using primers specific for the D region. 
Materials and Methods
Generation of V2 315m mice
In V2 315m mice, the germline Ig V2 exon 2 was replaced with a synthetic V2 315 (8) .
The targeting vector included a Neomycin resistance cassette positioned 5' of the V2 315 modified exon 2 sequence (See Fig. S3A above) . Genomic targeting of BALB/c BL1 ES cells was performed at Ozgene as described (8) . Transformed cells were selected and genomic integration was verified by Southern blots. ES clones were then injected into blastocysts of pseudopregnant mice. The resulting chimeric mice were crossed and the offspring typed by Southern blotting to verify germline transmission. The Neo r cassette was removed through breeding to an Flp-deleter line (Oz_Flp). The Flp gene was then removed through crossing with BALB/c mice. Thereafter, homozygous offspring (V2 315m+/+ ) mice were generated, and colonies were maintained in the homozygous state. 
B cell phenotyping
Characterization of splenic, lymph node and femoral bone marrow B cells was done by flow cytometry and analyzed essentially as in (7) . The 2B6 mAb (9) was used to select B cells that expressed a 2/3 L chain BCR. (10) . The resulting fusion protein was purified from cell culture supernatant by immobilized metal affinity chromatography using a HisTrap HP column (GE Healthcare). The purified protein was mixed with RIBI adjuvant (Sigma Aldrich) according to the supplied protocol, and the emulsion was used for vaccination of BALB/c mice by s.c. injection of 2x100 µg antigen at separate sites. Booster doses were administered on day +21 and +35. cDNA was prepared from splenocytes of the mouse with the highest titers of serum antibodies that bound pId 315 -pulsed A20 (I-E d+ ) B lymphoma cells, and a scFv phage library was constructed essentially as described using a high valence pIX display system (11) . scFv constructs reactive against pId 315 :I-E d complexes were selected by cell-based biopanning of phages using A20 cells loaded with synthetic pId 315 (a.a. 89-105) peptide. Top candidates were screened by flow cytometry. Briefly, pId 315 -pulsed and unpulsed A20 cells were incubated on ice for 45 min with phage-containing 2xYT bacterial supernatants diluted in PBS, followed by 30 min incubation with biotinylated rabbit anti-fd Bacteriophage antibodies (B2661, Sigma-Aldrich), and finally 25 min with Streptavidin-Phycoerythrin (BD). Binders showing preferential staining with peptide-pulsed A20 cells were reformatted into a His-tagged scFv format and biotinylated using EZ-Link NHS-Biotin (Thermo Scientific) followed by assessment for binding to cells by flow cytometry. The selected clone was sequenced and transferred to a pHOG21 periplasmic expression vector (12) . The scFv was expressed in E. coli, purified using a HiTrap protein L affinity chromatography column (GE Healthcare), and biotinylated using the EZ-Link Sulfo-NHS-Biotin reagent (Thermo Fischer Scientific). 
Materials and Methods
Generation of a TCR mimetic specific for pId:MHCII
Materials and Methods
Generation of F(ab) 2 fragments
The anti-Id IgG Ab2-1.4 was digested with immobilized Ficin and purified using a Protein A Spin column (Mouse IgG1 F(ab) 2 preparation kit, #44980, Pierce, Rockford, IL). Further removal of undigested IgG was done on a protein G column. SDS-PAGE was run under reducing conditions to verify relative absence of residual Fc fragments. Antigen binding was verified on ELISAs.
Plates were coated with 2 µg/ml of M315 (IgA, 2). Anti-Id IgG and anti-Id F(ab) 2 fragments were added followed by detection with anti-mouse--biotin (187.1). A commercial mouse IgG F(ab) 2 (Novusbio, NBP1-97018) was used as a control. 
Materials and Methods
In vitro generation of memory T cells
Id-specific Th2 cells were generated as in Munthe et al. (13) . Briefly, splenocytes and pooled LN cells from Id-specific TCR-TG mice were isolated by CD4 + T cell enrichment (negative selection, Miltenyi kits and columns) and stimulated in the presence of irradiated BALB/c splenocytes (APCs) added 1 µg/ml Id 315 peptide (FAALWFRNHFVFGGGTK) in the presence of 40 U/ml rec. murine IL-4 (#214-14, Peprotech) and 20 U/ml rec. murine IL-2 (#212-12, Peprotech). For in vivo studies, Th2 cultures (on day 8-10) were CD8-depleted using Lyt2 Dynabeads (11447D, Invitrogen), counted and assessed for viability and purity. Recovered cells were washed extensively in cell culture-grade 1X PBS before injection. 
Materials and Methods
Immunostaining for the GL7 activation marker
Frozen spleen sections were allowed to air dry, fixed in 4% neutral-buffered formalin, serum blocked for 45 minutes at room temperature, and incubated with rat-anti-mouse GL7-FITC (BioLegend, San Diego, CA, USA, #144603, clone GL7, 1:100) for 1hr at room temperature. Thereafter, the sections were rinsed and probed with anti-FITC-biotin (Sigma-Aldrich Corp., St. Louis, MO, USA, clone FL-D6, 1:400) for 1 hr. at room temperature, before rinsing again and peroxidase-quenching with 1% H 2 O 2 in PBS. The sections were finally incubated with peroxidase-conjugated ABC reagent (Vectorlabs, Burlingame, CA, USA) for 30 min. at room temperature. The antibody label was visualized by using 3'3'-diaminobenzidine (DAB, Sigma Aldrich) and nuclei were counterstained with hematoxylin. 
Materials and Methods
Immunofluorescence and quantification on tissue sections
Frozen spleen sections were equilibrated to room temperature, fixed in acetone and blocked using 30% normal mouse serum and 10 µg/ml purified anti-FcRmAb ( 
Materials and Methods
V L and V H sequencing in GC B cells
Pooled splenocytes from three Id 315 mice primed with naïve Id-sp. T cells and anti-Id F(ab) 2 as a BCR ligand were prepared on day 7 post-ligation. Splenocytes were incubated on ice with biotinylated peanut agglutinin (B-1075, VectorLabs) followed by anti-biotin magnetic microbeads (#130-105-637, Miltenyi) and positively sorted on MS columns (#130-042-201, Miltenyi). Flow-through (non-PNA-reactive) cells were also collected. Cells were rinsed in PBS and cell pellets were frozen at -80C. Total RNA was isolated using the RNA Easy kit (Qiagen) and cDNA prepared using a kit (K1612, Thermo Scientific). The transcripts were PCRamplified using the forward primers mV1/2 (5'-CAGGCTGTTGTGACTCAGGAATC-3') together with the downstream primers mC-outer (5'-GTACCATYTGCCTTCCAGKCCACT-3') that anneal to C1, C2 and C3, as published (14) . PCR products were TOPO-cloned using Zero blunt TOPO PCR cloning kit (450245, Thermo Fisher Scientific). Colonies were selected on LB plates containing Kanamycin. Small scale DNA preps were made from overnight cultures of single colonies using SV miniprep kit (Promega). Heavy chain transcripts were amplified using an upstream primer that aligns to the FR1 region of V H 315 and of VH3-6*02 (5′-GATGTACAGCTTCAGGAGTCAGGACCT-3') in combination with downstream primers against IgG C-regions: 5′-ATAGACAGATGGGGGTGTCGTTTTGGC-3' (IgG1) and 5′-AGGGACCAAGGGATAGACAGATGG-3' (IgG3). Small-scale DNA preps were sent for sequencing and analyzed. Sequences were analyzed using CLC Sequence Viewer v8.0 (Qiagen). 
Materials and Methods
Intracellular staining for Id + Ig
Splenocytes isolated from individual mice were cell surface-stained and then rinsed, fixed, permeabilized and stained using BD Cytofix/Cytoperm TM Kit (Cat. #554714) according to the manufacturer's instructions. Intracellular Id + Ig was detected using the Ab2-1.4 mAb directly conjugated to Alexa Fluor-488. 
Materials and Methods
LPS stimulation and transfer of blasts
Materials and Methods
ELISPOT assays
Bone marrow cells from both tibia were harvested from mice (n=3 per group) and single cell suspensions were prepared. MultiScreen HTS filter plates (MSIPS45, Merck Millipore Ltd., Tullagreen, Ireland) were coated with 12μg/well of AM5 (anti-Id IgM) or Ab2-1.4 (anti-Id IgG) over night at 4° C. Bone marrow cell suspensions were seeded and incubated for 20h. Spots were detected with anti-mouse IgG-AP (A1418, Sigma-Aldrich) or anti-mouse IgM-AP (A9688) at 1:5000 and developed with BCIP ® /NBT (B3679, Sigma Aldrich). ELISPOT plates were analyzed in CTL-ImmunoSpot® analyzer (CTL, Shaker Heights, OH, USA). Table. The ELISAs used either anti-hIgG3 as coat (MCA878G, AbD Serotec, 1:1000) when detected with Ab2-1.4-biotin and Ab2-TH-biotin (both at 1 µg/ml) or anti-hIgG3-biotin as a detection reagent (HP6017, Sigma, 1:1000) with TNP 12 OVA or DNP 5 BSA as coat. The biotinylated antibodies were probed using streptavidin-HRP and developed with TMB substrate solution (Calbiochem) and stopped with 1M H 2 SO 4 . Absorbance was measured at 450nm.
Materials and methods
Expression of V H and V L regions for specificity studies
Extended Materials and Methods
Ethics statement, animal experiments
The in vivo procedures followed institutional guidelines of the Department of Comparative Medicine, Oslo University Hospital. The project was approved by the Norwegian Food Safety Authority (ID#7414).
Generation of an anti-idiotypic IgM specific for M315
To generate a detection reagent specific for Id + IgG, Id 315 -specific B cell hybridomas were established from aId DKI mice (7) using standard procedures. Individual clones were isolated and assayed for heavy chain isotype and binding to M315. Clones producing anti-Id 315 antibodies with IgM heavy chains were isolated and expanded for large scale production. PCR products were generated from one clone (AM5-1-3) of a hybridoma using specific primers for the heavy-and light chain sequences in aId DKI mice (7), which were then sequenced. IgM was purified on 187.1 (rat anti-mouse  light chain) coupled Sepharose 4B columns. SDS-PAGE was done to ascertain purity, and specificity was confirmed by ELISA after biotinylation.
Generation of targeted VDJ H
315 knock-in mice Mice that express the V-region of the M315 myeloma protein heavy chain, produced by the MOPC315 multiple myeloma cell line (6) were generated by inserting the rearranged VDJ H Figure 2F -H) and to investigate binding specificities (Supplemental Table 1 ); otherwise, Ab2-1.4 was used. As a nonspecific isotype-matched control, we used purified MOPC21 IgG1 (M9269, Sigma, St. Louis, Missouri). F(ab) 2 fragments prepared from complete Ab2-1.4 were purified and characterized in the laboratory (see Supporting Online Material, Supplemental Figure 10 ). Mouse IgG F(ab) 2 (Novusbio, NBP1-97018) served as a specificity control.
In vitro stimulation cultures
In vitro stimulation cultures were set up using 2x10
5 Id-sp. T cells and 5x10 5 Id + B cells per well in flat-bottom 24-well plates (800 μL volume). BCR ligands or their controls were added to the cultures in titrated doses, typically ranging from 0.01-10 μg/mL. The cultures were incubated for four days before analysis. Where used, BrdU to 1mM was added for the last 14-16 hours before staining for cell surface markers and BrdU incorporation (BD Biosciences, #552598). For conjugate assays, enriched B and T cells were labeled with CTV and CFSE, respectively. B cells were incubated with anti-Id IgG for 60 minutes at 37 °C before mixing with Id-sp. T cells, followed by centrifugation at 70G and incubation in a humidified cell culture incubator to allow conjugate formation. Non-specific conjugates were broken up by mild shaking for 10 seconds (300 rpm, tabletop shaker) before fixing in 1% PFA and FACS analysis.
In vivo transfer experiments
Cells were enriched as described above, and the numbers of viable, specific cells (Id + B or Idspecific T) were calculated using trypan dye exclusion and by FACS staining. Enriched cells were extensively rinsed in cell culture grade PBS and re-suspended to yield the desired dose of viable, specific cells in 200 μL volume for injection into the tail vein. When both purified B and T cells were injected, these were mixed immediately before injection and kept on ice. BCR ligands and appropriate controls were dialyzed against two changes of sterile cell culture grade PBS for 4 hrs or over night at 4°C. BCR ligands (in 200 μL volume) were injected i.v. the day after cell transfer. For BrdU labeling, the mice received one i.p. injection of 1 mg BrdU the day after ligand injection, followed by provision of 600 μg/mL of BrdU (Sigma Aldrich) in the drinking water until termination of the experiment. Short term experiments proceeded for 7-13 days post-ligation. Recipients for transfer were Id 315 mice (described above) and CD45.1 + congenic mice (CByJ.SJL (B6)-Ptprca/J, #006584, JaxLabs, USA), all on the BALB/c background.
ELISAs for Id + IgG and Id + IgM Blood was harvested from the mice by saphenous vein puncture and sera prepared by centrifugation at 17,000 rpm in a tabletop centrifuge for 10 minutes. For detection of Id + IgG that bound the Ab2-1.4 IgM analogue AM5 (see above), 96-well ELISA plates (Costar 3590, Corning, NY, USA) were coated at 4° C over night with an equivalent mixture of rat-anti-mouse IgG1, IgG2a, IgG2b and IgG3 antibodies (1 μg/ml each; Southern Biotech, #1144-01, #1155-01, #1186-01, #1191-01). Captured IgG was detected using biotinylated AM5 (see above). Standard curves for total IgG and for IgG1 were based on an affinity-purified Id+ IgG1 from a 2 315 TG x VDJ H 315 mouse-derived hybridoma line (clone PK2). For Id + IgG isotype-specific detection, 2 μg/mL of the appropriate isotype specific rat anti-mouse IgG was used as coat and detection was performed as for total IgG. For Id + IgG2a, IgG2b and IgG3, serum cutoff values were established on each ELISA plate from several (≥3) individual BALB/c mice. For detection of Id + IgM, plates were coated with anti-Id IgG (Ab2-1.4, 2 μg/ml) and probed using anti-IgM-AP (2 μg/ml, A9688, Sigma Aldrich) or by coating plates with rat anti-mouse anti-IgM (2 μg/ml; Southern Biotech, 1139-01) and detected using Ab2-1.4-biotin. An IgM standard curve was generated using a purified IgM (clone PK8) from a 2 315 TG x VDJ H 315 mouse hybridoma. For measurements of DNP-specific Ig, the plates were coated using DNP5BSA (5 μg/ml) and captured antibodies were detected using reagents directed against mouse H chain isotypes and subclasses. Biotinylated secondary antibodies were probed using streptavidin-alkaline phosphatase (RPN1234, GE Healthcare, Buckinghamshire, UK). Plates were developed using AP substrate (P4744, Sigma Aldrich).
Antibodies and flow cytometry
The following mAbs were produced and affinity purified in the laboratory, followed by conjugation to biotin, Alexa Fluor 488, Alexa Fluor 546 or PE using standard procedures: anti-Id mAb Ab2-1.4 (IgG1), clonotype-specific GB113 mAb that binds the TCR of Id-specific T cells from TCR-TG mice (IgG2a, (18) ), 2B6 (anti-C2/3 (9)), 187.1 (anti-), 9A8 (anti-V1/2 (9)). mAbs with the following specificities were purchased from eBioscience: CD25 (PC61. 
Peptide stimulation experiments
Peptides for stimulation of Id-specific T cells had the following sequences: FAALWFRNHXVFGGGTK where X98 is F, Y, L or W. Peptides were synthesized >98% pure and verified by mass spectrometry (Think Peptides, Oxford, UK). Peptides were reconstituted at 10 mg/ml in cell culture grade DMSO and stored at -20 °C. For stimulation experiments, the peptides were diluted in tissue culture medium.
Lambda amplicon sequencing of B cells from the V2
315m mouse B cells were positively sorted from the spleens of a young naïve heterozygous V2 315m mouse using a CD19-selection kit (Miltenyi) and total RNA was isolated using an RNA Easy Kit (Qiagen). 5 μl RNA was used for cDNA generation using kit (K1612, Thermo Scientific). cDNA quality was evaluated using primers for GAPDH included in the kit. The  gene was extended for 20 cycles using primers mV1/2 (5'-CAGGCTGTTGTGACTCAGGAATC-3') and mC-outer (5'-GTACCATYTGCCTTCCAGKCCACT-3') as published (15) . The purified PCR products were subjected to purity check using gel electrophoresis and A 260/280 and A 260/230 measurements.
The amplicons (about 1 μg) were subject to Illumina miSeq sequencing. The amplicon sequences (2.7x10 6 reads) in a bam file were used to align the sequences and assign them to V, J and C segments. Counting and plotting was done in Rstudio and the software tool Knitr. Low level filtering was done in Rstudio to exclude sequences with somatic mutations in V-segments, which were assumed to be from non-naïve B cells. 2009488 reads were mapped in the bowtie2 alignment program using relaxed parameters.
Immunofluorescence and quantifications on sections
Spleen cryosections were air-dried, fixed in acetone and blocked using 30% normal rat serum added 5% BSA and 5% FCS in PBS. Primary reagents: goat anti-mouse -FITC (1:200, GLBF-90F, Immune Systems Ltd.) and peanut agglutinin lectin (1:600, PNA-Alexa Fluor 594, Molecular Probes) were added for 1 hour at room temperature, whereas rat-anti mouse ER-TR7 (1:100, BioRad, MCA2402) was incubated at 4°C overnight. Secondary reagent was rabbit antirat F(ab) 2 -DyLight 405 (Star16D405GA, BioRad). For quantification of germinal centers in spleens, each data point represented the average number of GCs counted per x10 microscopic field, pooled group-wise (d3, d6 or d9 and isotype-matched IgG control). 10-12 transversal sections from each mouse spleen spanning over a 1-2 mm were used to give a representative overview. For quantifications of T-B synapses, immunofluorescence was performed as given in Supplemental Figure 14 . Each data point on the graph represents the number of cell-to-cell contacts between Id + B and Id-specific T cells counted in one x20field. Data were pooled and compared group-wise (d3, d6 or d9 and isotype-matched IgG control on day 6).
Ca-flux measurements B cells from 2
315 TG x VDJ H 315 or BALB/c mouse spleens were enriched through depletion and incubated in complete media for 60 min at 37°C (2.25x10 6 c/ml) with Fluo-4 Direct™ calcium reagent (Fluo-4 Direct™ Calcium Assay Kit, F10471, Thermo Fisher Scientific) according to manufacturer's instructions. Baseline was recorded for 30 seconds, then ligand was added and the sample was recorded for 300 seconds. Samples were acquired on BD LSR II flow cytometer (BD Biosciences).
Phosphotyrosine blotting B cells were enriched from 2
315 TG x VDJ H 315 mouse spleens, washed and the pellet was stored on ice until stimulation. For stimulation, ≈2x10 6 B cells were re-suspended in warm (37°C) 1X PBS, and either anti-Id IgG or isotype control IgG was added (both 10 g/ml) for the indicated time points. Stimulation was stopped by adding 1ml of ice-cold PBS and the cells were centrifuged at 4°C immediately. Cells were lysed for 45 min at 4°C in NP-40 lysis buffer mixed with freshly prepared 0.5 mM Phenylmethylsulfonyl fluoride (P-470, GoldBio, St. Loius, MO, USA), 1mM sodium orthovanadate (450243, Sigma Aldrich), and protease inhibitor cocktail (P8340, Sigma Aldrich). Denatured samples were run on a 4-12% gel (NW04125BOX, Novex, Carlsbad, CA, USA) and transferred to a PVDF membrane (IB24001, Invitrogen). The membrane was blocked with 3% BSA (805095, Bio-Rad, Hercules, CA, USA) or milk powder (A0830, AppliChem, Darmstadt, Germany) in PBS-T, and incubated with either antiphosphotyrosine (clone 4G10, 1.0 μg/ml) in 3% BSA or anti-actin (612656, BD Biosciences, 0.5 μg/ml) in 3% milk powder. Primary antibodies were detected with goat anti-mouse IgG HRP (1030-05, Southern Biotech) and developed with ChemiGlow West Chemiluminescence Substrate Kit (60-12596-00, Proteinsimple, San Jose, CA, USA).
Statistics
Graph Pad Prism v5.01 and v7.02 was used for data plotting and analysis. The variables were inspected for normality. Flow cytometry data that passed were analyzed using two-tailed unpaired T tests with Welch′s correction for two groups, or using one-way ANOVA (Dunnett's test, two or more groups against a single control group) or Tukey's test (multiple comparisons ). For values that did not pass, two-tailed Mann-Whitney U test, or Dunn's test (Kruskal-Wallis test, multiple comparisons) were used. Serum antibody concentrations were compared using non-parametric tests, unless otherwise indicated. Means (±SEM or ±SD) are indicated on the scatter plots or bar graphs. All data points represent distinct biological samples. Significance levels: * p≤ 0.05, ** p≤ 0.01, *** p≤ 0.005, **** p≤ 0.001. n.s. not significant.
